ACS Publications. Most Trusted. Most Cited. Most Read
My Activity
CONTENT TYPES

Figure 1Loading Img

Total Synthesis of Vinblastine, Related Natural Products, and Key Analogues and Development of Inspired Methodology Suitable for the Systematic Study of Their Structure–Function Properties

View Author Information
Department of Chemistry and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States
*Dale L. Boger. E-mail: [email protected]
Cite this: Acc. Chem. Res. 2015, 48, 3, 653–662
Publication Date (Web):January 14, 2015
https://doi.org/10.1021/ar500400w

Copyright © 2015 American Chemical Society. This publication is licensed under these Terms of Use.

  • Open Access
  • Editors Choice

Article Views

16699

Altmetric

-

Citations

150
LEARN ABOUT THESE METRICS
PDF (5 MB)

Abstract

Conspectus

Biologically active natural products composed of fascinatingly complex structures are often regarded as not amenable to traditional systematic structure–function studies enlisted in medicinal chemistry for the optimization of their properties beyond what might be accomplished by semisynthetic modification. Herein, we summarize our recent studies on the Vinca alkaloids vinblastine and vincristine, often considered as prototypical members of such natural products, that not only inspired the development of powerful new synthetic methodology designed to expedite their total synthesis but have subsequently led to the discovery of several distinct classes of new, more potent, and previously inaccessible analogues.

With use of the newly developed methodology and in addition to ongoing efforts to systematically define the importance of each embedded structural feature of vinblastine, two classes of analogues already have been discovered that enhance the potency of the natural products >10-fold. In one instance, remarkable progress has also been made on the refractory problem of reducing Pgp transport responsible for clinical resistance with a series of derivatives made accessible only using the newly developed synthetic methodology. Unlike the removal of vinblastine structural features or substituents, which typically has a detrimental impact, the additions of new structural features have been found that can enhance target tubulin binding affinity and functional activity while simultaneously disrupting Pgp binding, transport, and functional resistance. Already analogues are in hand that are deserving of full preclinical development, and it is a tribute to the advances in organic synthesis that they are readily accessible even on a natural product of a complexity once thought refractory to such an approach.

 Special Issue

Published as part of the Accounts of Chemical Research special issue “Synthesis, Design, and Molecular Function”.

Originally isolated from Catharanthus roseus (L.) G. Don, (1-3) vinblastine (1) and vincristine (2) not only represent the most widely recognized members of the Vinca alkaloids but also one of the most important contributions that plant-derived natural products have made to cancer chemotherapy (Figure 1). (4-6) First introduced into the clinic over 50 years ago, their biological properties were among the first to be shown to arise from perturbations in microtubule dynamics that lead to inhibition of mitosis. Even by today’s standards, both vinblastine and vincristine are efficacious clinical drugs and are used in combination therapies for treatment of Hodgkin’s disease, testicular cancer, ovarian cancer, breast cancer, head and neck cancer, and non-Hodgkin’s lymphoma (vinblastine) or in the curative treatment regimens for childhood lymphocytic leukemia and Hodgkin’s disease (vincristine). They, as well as their biological target tubulin, remain the subject of extensive and continuing biological and synthetic investigations because of their clinical importance in modern medicine, low natural abundance, and fascinatingly complex dimeric alkaloid structure. (7-16)

Figure 1

Figure 1. Natural product structures.

Vinblastine and vincristine share an identical upper velbanamine subunit and contain nearly identical vindoline-derived lower subunits that differ only in the nature of the indoline N-substituent, bearing either a methyl (vinblastine) or formyl (vincristine) group (Figure 1). We reported the development of concise total syntheses of (−)- and ent-(+)-vindoline (17, 18) enlisting a tandem intramolecular [4 + 2]/[3 + 2] cycloaddition cascade of 1,3,4-oxadiazoles (19-25) in which the fully functionalized pentacyclic ring system is constructed in a single step. This occurs with formation of three rings and four C–C bonds and sets all six stereocenters within the central ring of vindoline, including its three quaternary centers (Figure 2). Moreover, the cycloaddition cascade introduces each substituent, each functional group, each embedded heteroatom, and all the necessary stereochemistry for direct conversion of the cycloadduct to vindoline. The reaction cascade is initiated by a [4 + 2] cycloaddition reaction of a 1,3,4-oxadiazole with a tethered dienophile, which entailed the use of an electron-rich enol ether whose reactivity and regioselectivity were matched to react with the electron-deficient 1,3,4-oxadiazole in an inverse electron demand Diels–Alder reaction. Loss of N2 from the initial cycloadduct provides a carbonyl ylide, which undergoes a subsequent 1,3-dipolar cycloaddition with a tethered indole. (16) For 3, the diene and dienophile substituents complement and reinforce the [4 + 2] cycloaddition regioselectivity dictated by the linking tether, the intermediate 1,3-dipole is stabilized by the complementary substitution at the dipole termini, and the tethered dipolarophile (indole) complements the [3 + 2] cycloaddition regioselectivity that is set by the linking tether. The relative stereochemistry of the cascade cycloadduct is controlled by a combination of the dienophile geometry and an exclusive indole endo [3 + 2] cycloaddition dictated by the dipolarophile tether and sterically directed to the face opposite the newly formed fused lactam. This methodology provided the basis for an 11-step total synthesis of (−)- and ent-(+)-vindoline. (18)

Figure 2

Figure 2. Key cycloaddition cascade.

Central to the further advancement of this work was the use of a biomimetic (9) Fe(III)-promoted coupling of vindoline with catharanthine (26, 27) and the additional development of a subsequent in situ Fe(III)-mediated hydrogen-atom initiated free radical alkene oxidation for C20′-alcohol introduction (27) that allows for their single-step incorporation into total syntheses of vinblastine, related natural products including vincristine, and key analogues (Figure 3). (16)

Figure 3

Figure 3. First generation total synthesis of vinblastine.

A subsequent asymmetric variant of this approach was developed in which the tether linking the initiating dienophile and 1,3,4-oxadiazole bears a chiral substituent that sets the absolute stereochemistry of the remaining six stereocenters in the cascade cycloadducts, providing two distinct and concise asymmetric total syntheses of vindoline (Figure 4). (28, 29) Since the approach enlisted a shortened dienophile tether that resulted in both good facial control and milder reaction conditions for the cascade cycloaddition, its implementation for the synthesis of vindoline required the development of a ring expansion reaction to provide a six-membered ring suitably functionalized for introduction of the Δ6,7-double bond found in the core structure of the natural product. Two unique approaches were developed that defined our use of a protected hydroxymethyl group as the substituent that controls the stereochemical course of the cycloaddition cascade. The first entailed a facile tautomerization of a reactive α-amino aldehyde generated from the primary alcohol, which is trapped as a remarkable N,O-ketal that undergoes a subsequent hydrolytic ring expansion upon further activation of the primary alcohol. (28, 29) The second approach relied upon a thermodynamically controlled reversible ring opening reaction of an intermediate aziridinium ion for which the stereochemical features of the reactions are under stereoelectronic control. (29) In the course of these studies, several analogues of vindoline were prepared containing deep-seated structural changes presently accessible only by total synthesis. (19-21)

Figure 4

Figure 4. Key elements of the asymmetric total synthesis approaches.

Prior to these efforts, the majority of vinblastine analogues were prepared by semisynthetic modification of peripheral substituents (tailoring effects), with the disclosure of a limited number of analogues that contain deep-seated structural changes. (30-33) As detailed herein, the powerful intramolecular [4 + 2]/[3 + 2] cycloaddition cascade has provided access not only to a series of analogues bearing systematic changes to the C5 ethyl substituent (34) but to a series of analogues bearing deep-seated structural modifications to the vindoline core ring system. (35) These latter efforts represent one of few examples of productive core structure redesign of a natural product.
Similarly, detailed herein are efforts to address the major limitation to the continued clinical use of vinblastine and vincristine, which is the emergence of resistance mediated by overexpression of the drug efflux pump phosphoglycoprotein (Pgp). The identification of structural analogues that might address such resistance has remained a major focus of the field and would represent a major advance for oncology therapeutics. With this objective in mind and by virtue of the unique methodology developed, we disclosed a series of C20′ urea derivatives (36-38) that not only possess extraordinary potency but also exhibit further improved activity against a Pgp overexpressing vinblastine-resistant human tumor cell line, displaying improved potency (10–30-fold) and a reduced difference in activity against a matched sensitive and resistant human tumor cell line (HCT116 vs HCT116/VM46, 10–20-fold vs 100-fold difference for vinblastine). (38) Although this site is known to be critical to the biological properties of vinblastine and is found to be deeply embedded in the tubulin bound complex, this study represented the first systematic examination of analogues bearing alternative C20′ functionality.
As highlighted earlier, a powerful Fe(III)-promoted coupling of catharanthine with vindoline generating anhydrovinblastine (26) was enlisted and combined with a newly developed in situ Fe(III)/NaBH4-promoted oxidation to provide vinblastine in a single operation (Figure 5). (27) This development not only converted the synthetic efforts into one capable of use for the systematic exploration of the vinblastine structure but also assured that supplies of any analogue needed for preclinical studies or clinical introduction could be accessed by total synthesis. Consequently, in addition to its use in the completion of the total syntheses of vinblastine (12 steps), vincristine, and a series of additional naturally occurring Vinca alkaloids, (16) the approach also permits the incorporation of vindoline analogues containing single site peripheral changes to the structure as well as more deep-seated changes to the vindoline core accessible only by total synthesis.

Figure 5

Figure 5. Single-step coupling and in situ oxidation and representative vinblastine analogues prepared by total synthesis.

An early example of the power of the approach entailed systematic replacements of the vindoline C5 ethyl group, which were introduced as alternative substituents on the oxadiazole tethered dienophile in the cascade cycloaddition substrate. (34) Their examination revealed the surprising importance of the C5 ethyl substituent where even conservative methyl (10-fold), hydrogen (100-fold), or propyl replacements (10-fold) led to significant reductions in activity (Figure 6). (34)

Figure 6

Figure 6. Probing the importance of the C5 ethyl group.

Further representative of the opportunities the work has provided and complementary to the vindoline 6,5-DE ring system, 5,5-, 6,6-, and the reversed 5,6-membered DE ring system analogues that contain deep-seated changes to the core structure were prepared (Figure 5). (35) Preparation of these analogues, not accessible from natural product sources, further demonstrates the versatility of the intramolecular [4 + 2]/[3 + 2] cycloaddition cascade. Both the natural cis and unnatural trans 6,6-membered DE ring systems proved accessible, with the latter unnatural stereochemistry representing a surprisingly effective class for analogue design. After Fe(III)-promoted coupling with catharanthine and in situ oxidation to provide the corresponding vinblastine analogues, their evaluation provided unanticipated insights into how the structure of the vindoline subunit contributes to activity. Two potent analogues possessing two different unprecedented modifications to the vindoline subunit core architecture were discovered that matched the potency of the comparison natural products. Remarkably, both lack the 6,7-double bond whose removal in vinblastine leads to a 100-fold loss in activity, and both represent the most dramatic departures from the structure of vindoline of those examined to date. Thus, although single functional group removals from the vinblastine lower subunit typically result in pronounced and additive losses in activity, (28) two unprecedented deep-seated structural changes to the core structure were found that maintain potent activity. Significantly and unlike modifications of peripheral substituents (tailoring effects), core structure redesign in such complex natural products is rarely explored, and the results in this series indicate this may offer far more opportunities than most might anticipate. (35)
Ongoing efforts have also begun to define catharanthine substituents that are required for the Fe(III)-promoted biomimetic coupling with vindoline, and these include (1) a probe of the importance of the C16′ methyl ester and requirement for a C16′ electron-withdrawing group for coupling, (39) and (2) a Hammett series of C10′ indole substituents where electron-donating substituents were found to maintain and electron-withdrawing substituents to progressively slow the rate and efficiency of coupling. (40) The former unexpectedly revealed that even conservative replacements of the vinblastine C16′ methyl ester with an ethyl ester (10-fold), a cyano group (100-fold), an aldehyde (100-fold), a hydroxymethyl group (1000-fold), or a primary carboxamide (>1000-fold) led to surprisingly large reductions in biological activity, indicating that the C16′ methyl ester is not only required for the biosynthetic coupling but uniquely integral to the expression of vinblastine’s biological properties (Scheme 1). (39)

Scheme 1

The latter study, which included an examination of the impact of catharanthine C10′ and C12′ indole substituents on the Fe(III)-mediated coupling with vindoline, led to the discovery and characterization of two new exciting derivatives, 10′-fluorovinblastine and 10′-fluorovincristine (Figure 7). (40) In addition to defining a pronounced unanticipated substituent effect on the biomimetic coupling that helped refine its mechanism, (41) fluorine substitution at C10′ was found to uniquely enhance the activity 8-fold against both a sensitive (IC50 = 800 pM, HCT116) and a vinblastine-resistant tumor cell line (IC50 = 80 nM, HCT116/VM46). As depicted in the X-ray structure of vinblastine bound to tubulin, this site resides at one end of the upper portion of the T-shaped conformation of the tubulin-bound molecule, suggesting that the 10′-fluorine substituent makes critical contacts with the protein at a hydrophobic site uniquely sensitive to steric interactions. With the development of an effective single-step coupling and in situ oxidation protocol for convergent analogue assemblage, the synthesis and evaluation of a systematic series of C10′ and C12′ analogues were possible. Although C12′ substituents were not well tolerated, C10′ substituents were. Moreover and with the provision that C10′ polar substituents are not well tolerated, the activity of the vinblastine C10′ derivatives in cell-based assays exhibited no apparent relationship to the electronic character of the substituents but rather exhibited activity that correlates with their size and shape [activity for analogue R = H < F > Cl > Me, Br ≫ I, SMe (10-fold) ≫ CN (100-fold)]. Thus, small hydrophobic C10′ substituents are tolerated with one derivative exceeding (R = F) and several matching the potency of vinblastine (R = Cl, Me, Br vs H), whereas those bearing the larger (R = I, SMe) or rigidly extended (R = CN) substituents proved to be 10–100-fold less potent. With a recognition that the 10′-fluoro substitution conveys uniquely potent activity to such Vinca alkaloids, 10′-fluorovincristine was also prepared. Thus, Fe(III)-promoted coupling (70%) of synthetic 10-fluorocatharantine with synthetic N-desmethylvindoline (16) and subsequent in situ Fe(III)-mediated oxidation provided 10′-fluoro-N1-desmethylvinblastine, which was formylated to provide synthetic 10′-fluorovincristine. Like 10′-fluorovinblastine, 10′-fluorovincristine exhibited exceptional activity in the cell-based functional assays, inhibiting tumor cell growth 8-fold more potently than vincristine itself (Figure 7). (40)

Figure 7

Figure 7. 10′-Fluorovinblastine and 10′-fluorovincristine.

Although the enhanced oxidative metabolic stability of the 10′-fluoro derivatives may contribute to the increased potency, the lack of similar effects with closely related substituents indicate that an effect unique to the fluorine substitution is responsible. We have suggested that this is derived from the interaction of a perfectly sized hydrophobic substituent further stabilizing the compound binding with tubulin at a site exquisitely sensitive to steric interactions. Comparison models of the 10′ substituent analogues built from the X-ray structure of tubulin-bound vinblastine (39) illustrated a unique fit for 10′-fluorovinblastine (Figure 8). (40)

Figure 8

Figure 8. Space filling model of the 10′-fluoro binding site of 10′-fluorovinblastine (R = F, top) generated by adding the fluorine substituent to the X-ray structure of tubulin-bound vinblastine (43) (R = H, bottom). (40) Comparison models where R = Cl, Br, and I illustrated the unique fit for F, and the complexes exhibited increasingly larger destabilizing steric interactions as the substituent size progressively increased.

In order to confirm that the exceptional activity observed in our lab would be observed elsewhere, we had vinblastine and 10′-fluorovinblastine examined in a more comprehensive human tumor cell line panel including cell lines of clinical interest from breast, lung, colon, prostate, and ovary tissue (Figure 9) graciously conducted at Bristol-Myers Squibb. (42) 10′-Fluorovinblastine exhibited remarkable potency (avg IC50 = 300 pM), being on average 30-fold more potent than vinblastine (avg IC50 = 10 nM) and exceeding our more conservative initial observations.

Figure 9

Figure 9. 10′-Fluorovinblastine human tumor cell growth inhibition.

A further delineation of the scope of aromatic substrates that participate with catharanthine in the Fe(III)-mediated coupling reaction, the definition of its key structural features required for participation in the reaction, and its extension to a generalized indole functionalization reaction that bears little structural relationship to catharanthine were defined. (41) In addition to revealing that the exclusive diastereoselectivity of the coupling reaction that installs the key C16′ center is controlled by the catharanthine-derived coupling intermediate, the studies provided key insights into the mechanism of the Fe(III)-mediated coupling reaction of catharanthine, suggesting that the reaction conducted in acidic aqueous buffer may result from a single-electron indole oxidation and may be radical mediated. Just as importantly, the studies provide new opportunities for the synthesis of previously inaccessible Vinca alkaloid analogues (Scheme 2) and defined powerful new methodology for the synthesis of indole-containing natural products. (41)

Scheme 2

Similarly, detailed investigations of the second stage of the coupling process, the Fe(III)-mediated free radical oxidation of the anhydrovinblastine trisubstituted alkene to introduce the vinblastine C20′ tertiary alcohol, revealed insights into not only its mechanism but also the synthesis of previously inaccessible vinblastine analogues. Initial studies revealed that it is a free radical mediated oxidation reaction, that the reaction is initiated by the addition of NaBH4 to the Fe(III) salt, and that reactions in the absence of air (O2) led to reduction of the double bond (Figure 10). (16) Subsequent studies provided additional details of the mechanism of the reaction, entailing a hydrogen atom transfer (HAT) initiated free radical reaction, (44) and defined a new method for the direct functionalization of unactivated alkenes. (36) Included in these studies was a definition of the alkene substrate broad scope, the reaction’s extensive functional group tolerance, the establishment of exclusive Markovnikov addition regioselectivity, the use of a wide range of alternative free radical traps for O, N, S, C, and halide substitution, an examination of the Fe(III) salt and the hydride source best suited to initiate the reaction, the introduction of alternative reaction solvents beyond the water and aqueous buffer (27) originally disclosed, and the exploration of catalytic variants of the reactions. (36) The reaction was extended to a powerful Fe(III)/NaBH4-mediated free radical hydrofluorination of unactivated alkenes using Selectfluor as the fluorine atom source. (45) Unlike the traditional and unmanageable free radical hydrofluorination of alkenes, the Fe(III)/NaBH4-mediated reaction is conducted under exceptionally mild conditions (0 °C, 5 min, CH3CN/H2O), uses a technically nondemanding reaction protocol, is conducted open to the air with water as a cosolvent, demonstrates an outstanding substrate scope and functional group tolerance, and is suitable for 18F introduction (t1/2 =110 min) used in PET imaging. (45)

Figure 10

Figure 10. Hydrogen atom transfer (HAT) free radical oxidation of anhydrovinblastine and generalization of the methodology for unactivated alkene functionalization.

Our interest in this Fe(III)/NaBH4-mediated reaction emerged not only from its use in accessing vinblastine but from the opportunity it presented for the late-stage, divergent (46) preparation of otherwise inaccessible vinblastine analogues incorporating alternative C20′ functionality. Although this site is known to be critical to the properties of vinblastine and is found deeply embedded in the tubulin bound complex (Figure 11), (43) prior exploration of C20′ substituent effects was limited to semisynthetic O-acylation of the C20′ alcohol, its elimination and subsequent alkene reduction, or superacid-catalyzed additions. (47) These invariably led to substantial reductions in biological potency of the resulting derivative, albeit with examination of only a limited number of analogues. Consequently and in the course of the development of the Fe(III)/NaBH4-mediated alkene functionalization reaction, its use was extended to the preparation of a series of key vinblastine analogues bearing alternative C20′ functionality (e.g., N3, NH2, and SCN vs OH). (36) Those of initial interest included the C20′ azide and amine, both of which proved to be approximately 100-fold less potent than vinblastine and 10-fold less potent than 20′-deoxyvinblastine. However, acylation of the C20′ amine improved activity 10-fold (36) and installation of the unsubstituted C20′ urea or thiourea provided compounds that nearly matched the potency of vinblastine itself (Figure 11). (36, 37) The requisite NH of the internal nitrogen of the latter series presumably best recapitulates the H-bond donor property of the vinblastine C20′ alcohol.

Figure 11

Figure 11. (top) Initial C20′ vinblastine analogues. (bottom) X-ray structure (43) of vinblastine bound to tubulin highlighting the region surrounding vinblastine C20′ site.

On the basis of these results and with the further observation that the site had an apparent pronounced impact on Pgp transport, we conducted a systematic exploration of C20′ amine, urea, and thiourea derivatives, which provided C20′ urea-based analogues that not only substantially exceed the potency of vinblastine but also exhibited good activity against a Pgp overexpressing, vinblastine-resistant tumor cell line. Thus, members in this group not only exceed the potency of vinblastine (10-fold) but exhibit even further improved activity against vinblastine-resistant cell lines (100-fold) in some cases, partially overcoming overexpressed Pgp transport. (37, 38)
Just as remarkably and in contrast to expectations based on the steric constraints of the tubulin binding site surrounding the vinblastine C20′ center depicted in the X-ray cocrystal structure of a tubulin bound complex, (43) large C20′ urea derivatives are accommodated (e.g., biphenyl), exhibiting potent functional activity in cell-based proliferation assays and effectively binding tubulin. (37)
Continued and ongoing studies have provided even more potent analogues as superb candidate drugs, especially for vinblastine-resistant relapse tumors (Figure 12). Thus, a series of disubstituted C20′-urea derivatives of vinblastine were prepared from 20′-aminovinblastine, accessible through the unique Fe(III)/NaBH4-mediated alkene functionalization reaction of anhydrovinblastine. They were found to not only possess extraordinary potency (IC50 = 40–450 pM) but also exhibit further improved activity against a Pgp overexpressing vinblastine-resistant cell line. (38) Three such analogs were examined across a panel of 15 tumor cell lines graciously conducted at Bristol-Myers Squibb, (38, 42) and each displayed remarkably potent cell growth inhibition activity (avg IC50 = 200–300 pM vs avg vinblastine IC50 = 6.1 nM) against a broad spectrum of clinically relevant human cancer cell lines, being on average 20–30-fold more potent than vinblastine (range of 10–200-fold more potent). Significantly, the analogues also display further improved activity against the vinblastine-resistant HCT116/VM46 cell line that bears the clinically relevant overexpression of Pgp, exhibiting IC50 values on par with that of vinblastine against the sensitive HCT116 cell line, 100–200-fold greater than the activity of vinblastine against the resistant HCT116/VM46 cell line, and display a reduced 10–20-fold activity differential between the matched sensitive and resistant cell lines (vs 100-fold for vinblastine). (38) Clearly, the C20′ position within vinblastine represents a key site amenable to functionalization capable of improving tubulin binding affinity, substantially enhancing biological potency, and simultaneously decreasing binding and relative Pgp transport central to clinical resistance. Compound 5 was found to bind tubulin with a higher affinity than vinblastine, confirming that its enhanced potency observed in the cell growth functional assays correlates with its target tubulin binding affinity. (38) Remarkable in these developments is the observation that the activity against the vinblastine-resistant, Pgp overexpressing cell line uniquely and progressively improves as the terminal nitrogen of the urea is substituted (R = H, H < R = H, Me < R = Me, Me), diminishes smoothly with introduction of polarity, and smoothly increases with introduction of increasing π-hydrophobic substitution reflecting tunable and now predictable structural features that enhance tubulin binding and simultaneously diminish Pgp binding and transport.

Figure 12

Figure 12. Disubstituted C20′ urea derivatives of vinblastine.

What is most remarkable about these advances and although it could not have been imagined at the stage we initiated our efforts, the C20′ analogues of vinblastine are available in three steps from commercially available materials (Scheme 3). Although vinblastine is a true trace natural product, representing 0.00025% of the dried leaf weight of the periwinkle, its biosynthetic precursors catharanthine and vindoline are the major alkaloid components of the plant. They are readily available, relatively inexpensive starting materials. As a result, such C20′ analogues are not only readily accessible using the unique chemistry we introduced but also inexpensive to prepare on scales needed for preclinical development. Thus, the innovative chemistry developed in route to the total synthesis of vinblastine–the Fe(III)-mediated single-step coupling of catharanthine and vindoline that proceeds with complete control of the pivotal C16′ stereochemistry and the in situ Fe(III)-mediated hydrogen atom transfer free radical functionalization (Markovnikov hydroazidation) (36) of the key C20′ center–permits the exploration of exciting analogues previously unimaginable. (48)

Scheme 3

Not only does this methodology mimic the biosynthetic pathway leading to vinblastine that has been presumed to be mediated by enzymes, but it is of special note that the diastereoselectivity of the Fe(III)-mediated coupling and subsequent oxidation reproduces the relative abundance of vinblastine and leurosidine (C20′ diastereomer) found in the plant. Moreover, it is known that catharanthine and vindoline are stored in plants spatially separated from one another. (49) This provocatively suggests that the low natural abundance of vinblastine (and leurosidine) may arise not from an orchestrated enzymatic coupling and subsequent functionalization of catharanthine and vindoline but rather by a stress-induced mixing of the two precursors in the presence of Fe(III) and air. Perhaps the chemistry we have developed is not simply biomimetic but constitutes nonenzymatic chemistry actually involved in the plant production of vinblastine.

Conclusions and Outlook

ARTICLE SECTIONS
Jump To

Those reading this Account may think the [4 + 2]/[3 + 2] cycloaddition cascade is powerful methodology and that vindoline and vinblastine represent perfect applications in which to showcase its potential. Truth is that it was the natural product targets vindoline and vinblastine, their importance in modern medicine, and the potential for their improvements that inspired the discovery of the synthetic methodology. Not only is the full pentacyclic skeleton of vindoline assembled in a single cycloaddition cascade, but each substituent, each functional group, each embedded heteroatom, and all the necessary stereochemistry are incorporated into the substrate and the cycloaddition cascade cycloadduct tailored for direct conversion to vindoline. It is methodology created for the intended target. Combined with the development of a powerful single-step Fe(III)-promoted coupling of catharanthine with vindoline and a newly developed in situ Fe(III)/NaBH4-promoted C20′ oxidation, the approach provides vinblastine and its analogues in 8–13 steps. With use of the methodology and in addition to systematically defining the importance of each embedded structural feature of vinblastine, two classes of analogues have already been discovered that enhance the potency of the natural products >10-fold. In one instance, progress has also been made on the refractory problem of reducing Pgp transport responsible for resistance with a series of C20′ amine derivatives uniquely accessible using the newly developed methodology. Unlike the removal of vinblastine structural features or substituents, which typically has a detrimental impact, the addition of new features can enhance target tubulin binding affinity and functional activity and, in selected instances, (50) simultaneously disrupt Pgp binding, transport, and functional resistance. Already analogues are in hand that are deserving of preclinical development, and it is a tribute to the advances in organic synthesis that they are accessible even on a natural product of a complexity once thought refractory to such an approach.

Author Information

ARTICLE SECTIONS
Jump To

  • Corresponding Author
    • Dale L. Boger - Department of Chemistry and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States Email: [email protected]
  • Author
    • Justin E. Sears - Department of Chemistry and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States
  • Notes
    The authors declare no competing financial interest.

Biographies

ARTICLE SECTIONS
Jump To

Dale L. Boger

Dale L. Boger is the Richard & Alice Cramer Chair in Chemistry at The Scripps Research Institute (1990-present) where he also serves as Chairman (2012–present) of the Department of Chemistry. He received his BS in Chemistry from the University of Kansas (1975) where he worked with Professor A. W. Burgstahler and his Ph.D. in Chemistry from Harvard University (1980) working with Professor E. J. Corey. He was on the faculty at the University of Kansas and Purdue University before joining TSRI in 1990.

Justin E. Sears

Justin E. Sears received his BS in Chemistry from Haverford College (2010) where he worked with Professor Frances Blase. He is currently a Ph.D. student at The Scripps Research Institute (2010–present) with Professor Boger.

Acknowledgment

ARTICLE SECTIONS
Jump To

We gratefully acknowledge the financial support of the National Institutes of Health (CA115526 and CA042056, DLB).

References

ARTICLE SECTIONS
Jump To

This article references 50 other publications.

  1. 1
    Noble, R. L.; Beer, C. T.; Cutts, J. H. Role of chance observations in chemotherapy: Vinca rosea Ann. N.Y. Acad. Sci. 1958, 76, 882 894
  2. 2
    Noble, R. L. Catharanthus roseus (vinca rosea): Importance and value of a chance observation Lloydia 1964, 27, 280 281
  3. 3
    Svoboda, G. H.; Nuess, N.; Gorman, M. Alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don.). V. Preparation and characterization of alkaloids J. Am. Pharm. Assoc. Sci. Ed. 1959, 48, 659 666
  4. 4
    Neuss, N.; Neuss, M. N. Therapeutic use of bisindole alkaloids from catharanthus. In The Alkaloids; Brossi, A.; Suffness, M., Eds.; Academic: San Diego, CA, 1990; Vol. 37, pp 229 240.
  5. 5
    Pearce, H. L. Medicinal chemistry of bisindole alkaloids from Catharanthus. In The Alkaloids; Brossi, A.; Suffness, M., Eds.; Academic: San Diego, CA, 1990; Vol. 37, pp 145 204.
  6. 6
    Kuehne, M. E.; Marko, I. Syntheses of vinblastine-type alkaloids. In The Alkaloids; Brossi, A.; Suffness, M., Eds.; Academic: San Diego, CA, 1990; Vol. 37, pp 77 132.
  7. 7
    Fahy, J. Modifications in the “upper” velbenamine part of the Vinca alkaloids have major implications for tubulin interacting activities Curr. Pharm. Des. 2001, 7, 1181 1197
  8. 8
    Potier, P. Synthesis of the antitumor dimeric indole alkaloids from catharanthus species (vinblastine group) J. Nat. Prod. 1980, 43, 72 86
  9. 9
    Kutney, J. P. Plant cell culture combined with chemistry: a powerful route to complex natural products Acc. Chem. Res. 1993, 26, 559 566
  10. 10
    Langlois, N.; Gueritte, F.; Langlois, Y.; Potier, P. Application of a modification of the Polonovski reaction to the synthesis of vinblastine-type alkaloids J. Am. Chem. Soc. 1976, 98, 7017 7024
  11. 11
    Kutney, J. P.; Hibino, T.; Jahngen, E.; Okutani, T.; Ratcliffe, A. H.; Treasurywala, A. M.; Wunderly, S. Total synthesis of indole and dihydroindole alkaloids. IX. Studies on the synthesis of bisindole alkaloids in the vinblastine-vincristine series. The biogenetic approach Helv. Chim. Acta 1976, 59, 2858 2882
  12. 12
    Kuehne, M. E.; Matson, P. A.; Bornmann, W. G. Enantioselective syntheses of vinblastine, leurosidine, vincovaline and 20′-epi-vincovaline J. Org. Chem. 1991, 56, 513 528
  13. 13
    Bornmann, W. G.; Kuehne, M. E. A common intermediate providing syntheses of ψ-tabersonine, coronaridine, iboxyphylline, ibophyllidine, vinamidine, and vinblastine J. Org. Chem. 1992, 57, 1752 1760
  14. 14
    Yokoshima, S.; Ueda, T.; Kobayashi, S.; Sato, A.; Kuboyama, T.; Tokuyama, H.; Fukuyama, T. Stereocontrolled total synthesis of (+)-vinblastine J. Am. Chem. Soc. 2002, 124, 2137 2139

    Additionally, see:

    Kuboyama, T.; Yokoshima, S.; Tokuyama, H.; Fukuyama, T. Stereocontrolled total synthesis of (+)-vincristine Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 11966 11970
  15. 15
    Magnus, P.; Stamford, A.; Ladlow, M. Synthesis of the antitumor bisindole alkaloid vinblastine: diastereoselectivity and solvent effect on the stereochemistry of the crucial C-15-C-18′ bond J. Am. Chem. Soc. 1990, 112, 8210 8212
  16. 16
    Ishikawa, H.; Colby, D. A.; Seto, S.; Va, P.; Tam, A.; Kakei, H.; Rayl, T. J.; Hwang, I.; Boger, D. L. Total synthesis of vinblastine, vincristine, related natural products, and key structural analogues J. Am. Chem. Soc. 2009, 131, 4904 4916
  17. 17
    Ishikawa, H.; Elliott, G. I.; Velcicky, J.; Choi, Y.; Boger, D. L. Total synthesis of (−)- and ent-(+)-vindoline and related alkaloids J. Am. Chem. Soc. 2006, 128, 10596 10612
  18. 18
    Choi, Y.; Ishikawa, H.; Velcicky, J.; Elliott, G. I.; Miller, M. M.; Boger, D. L. Total synthesis of (−)- and ent-(+)-vindoline Org. Lett. 2005, 7, 4539 4542
  19. 19
    Yuan, Z.; Ishikawa, H.; Boger, D. L. Total synthesis of natural (−)- and ent-(+)-4-desacetoxy-6,7-dihydrovindorosine and natural and ent-minovine: oxadiazole tandem intramolecular Diels–Alder/1,3-dipolar cycloaddition reaction Org. Lett. 2005, 7, 741 744
  20. 20
    Elliott, G. I.; Velcicky, J.; Ishikawa, H.; Li, Y.; Boger, D. L. Total synthesis of (−)- and ent-(+)-vindorosine: tandem intramolecular Diels–Alder/1,3-dipolar cycloaddition reaction of 1,3,4-oxadiazoles Angew. Chem., Int. Ed. 2006, 45, 620 622
  21. 21
    Ishikawa, H.; Boger, D. L. Total synthesis of natural (−)- and ent-(+)-4-desacetoxy-5-desethylvindoline Heterocycles 2007, 72, 95 102
  22. 22
    Elliott, G. I.; Fuchs, J. R.; Blagg, B. S. J.; Ishikawa, H.; Tao, H.; Yuan, Z.; Boger, D. L. Intramolecular Diels–Alder/1,3-dipolar cycloaddition cascade of 1,3,4-oxadiazoles J. Am. Chem. Soc. 2006, 128, 10589 10595
  23. 23
    Wilkie, G. D.; Elliott, G. I.; Blagg, B. S. J.; Wolkenberg, S. E.; Soenen, D. B.; Miller, M. M.; Pollack, S.; Boger, D. L. Intramolecular Diels–Alder and tandem intramolecular Diels–Alder/1,3-dipolar cycloaddition reactions of 1,3,4-oxadiazoles J. Am. Chem. Soc. 2002, 124, 11292 11294
  24. 24
    Boger, D. L. Diels–Alder reactions of azadienes Tetrahedron 1983, 39, 2869 2939
  25. 25
    Boger, D. L. Diels–Alder reactions of heterocyclic azadienes Chem. Rev. 1986, 86, 781 793
  26. 26
    Vukovic, J.; Goodbody, A. E.; Kutney, J. P.; Misawa, M. Production of 3′,4′-anhydrovinblastine: a unique chemical synthesis Tetrahedron 1988, 44, 325 331
  27. 27
    Ishikawa, H.; Colby, D. A.; Boger, D. L. Direct coupling of catharanthine and vindoline to provide vinblastine: total synthesis of (+)- and ent-(−)-vinblastine J. Am. Chem. Soc. 2008, 130, 420 421
  28. 28
    Sasaki, Y.; Kato, D.; Boger, D. L. Asymmetric total synthesis of vindorosine, vindoline, and key vinblastine analogues J. Am. Chem. Soc. 2010, 132, 13533 13544
  29. 29
    Kato, D.; Sasaki, Y.; Boger, D. L. Asymmetric total synthesis of vindoline J. Am. Chem. Soc. 2010, 132, 3685 3687
  30. 30
    Kuehne, M. E.; Bornmann, W. G.; Marko, I.; Qin, Y.; Le Boulluec, K. L.; Frasier, D. A.; Xu, F.; Malamba, T.; Ensinger, C. L.; Borman, L. S.; Huot, A. E.; Exon, C.; Bizzarro, F. T.; Cheung, J. B.; Bane, S. L. Syntheses and biological evaluation of vinblastine congeners Org. Biomol. Chem. 2003, 1, 2120 2136
  31. 31
    Miyazaki, T.; Yokoshima, S.; Simizu, S.; Osada, H.; Tokuyama, H.; Fukuyama, T. Synthesis of (+)-vinblastine and its analogues Org. Lett. 2007, 9, 4737 4740
  32. 32
    Voss, M. E.; Ralph, J. M.; Xie, D.; Manning, D. D.; Chen, X.; Frank, A. J.; Leyhane, A. J.; Liu, L.; Stevens, J. M.; Budde, C.; Surman, M. D.; Friedrich, T.; Peace, D.; Scott, I. L.; Wolf, M.; Johnson, R. Synthesis and SAR of vinca alkaloid analogues Bioorg. Med. Chem. Lett. 2009, 19, 1245 1249
  33. 33
    Gherbovet, O.; Coderch, C.; Alvarez, M. C. G.; Bignon, J.; Thoret, S.; Martin, M.-T.; Guéritte, F.; Gago, F.; Roussi, F. Synthesis and biological evaluation of a new series of highly functionalized 7′-homo-anhydrovinblastine derivatives J. Med. Chem. 2013, 56, 6088 6100
  34. 34
    Va, P.; Campbell, E. L.; Robertson, W. M.; Boger, D. L. Total synthesis and evaluation of a key series of C5-substituted vinblastine derivatives J. Am. Chem. Soc. 2010, 132, 8489 8495
  35. 35
    Schleicher, K. D.; Sasaki, Y.; Tam, A.; Kato, D.; Duncan, K. K.; Boger, D. L. Total synthesis and evaluation of vinblastine analogues containing systematic deep-seated modifications in the vindoline subunit ring system: core redesign J. Med. Chem. 2013, 56, 483 495
  36. 36
    Leggans, E. K.; Barker, T. J.; Duncan, K. K.; Boger, D. L. Iron(III)/NaBH4-mediated additions to unactivated alkenes: synthesis of novel 20′-vinblastine analogues Org. Lett. 2012, 14, 1428 1431
  37. 37
    Leggans, E. K.; Duncan, K. K.; Barker, T. J.; Schleicher, K. D.; Boger, D. L. A remarkable series of vinblastine analogues displaying enhanced activity and an unprecedented tubulin binding steric tolerance: C20′ urea derivatives J. Med. Chem. 2013, 56, 628 639
  38. 38
    Barker, T. J.; Duncan, K. K.; Otrubova, K.; Boger, D. L. Potent vinblastine C20′ ureas displaying additionally improved activity against a vinblastine-resistant cancer cell line ACS Med. Chem. Lett. 2013, 4, 985 988
  39. 39
    Tam, A.; Gotoh, H.; Robertson, W. M.; Boger, D. L. Catharanthine C16 substituent effects on the biomimetic coupling with vindoline: preparation and evaluation of a key series of vinblastine analogues Bioorg. Med. Chem. Lett. 2010, 20, 6408 6410
  40. 40
    Gotoh, H.; Duncan, K. K.; Robertson, W. M.; Boger, D. L. 10′-Fluorovinblastine and 10′-fluorovincristine: synthesis of a key series of modified Vinca alkaloids ACS Med. Chem. Lett. 2011, 2, 948 952
  41. 41
    Gotoh, H.; Sears, J. E.; Eschenmoser, A.; Boger, D. L. New insights into the mechanism and an expanded scope of the Fe(III)-mediated vinblastine coupling reaction J. Am. Chem. Soc. 2012, 134, 13240 13243
  42. 42

    We thank Gregory Vite and Robert Borzilleri for arranging and overseeing this assessment and Craig Fairchild, Kathy Johnson, and Russell Peterson for conducting the testing at Bristol–Myers Squibb.

  43. 43
    Gigant, B.; Wang, C.; Ravelli, R. B. G.; Roussi, F.; Steinmetz, M. O.; Curmi, P. A.; Sobel, A.; Knossow, M. Structural basis for the regulation of tublin by vinblastine Nature 2005, 435, 519 522
  44. 44
    Iwasaki, K.; Wan, K. K.; Oppedisano, A.; Crossley, S. W. M.; Shenvi, R. A. Simple, chemoselective hydrogenation with thermodynamic stereocontrol J. Am. Chem. Soc. 2014, 136, 1300 1303

    Also see:

    Lo, J. C.; Yabe, Y.; Baran, P. S. A practical and catalytic reductive olefin coupling J. Am. Chem. Soc. 2014, 136, 1304
  45. 45
    Barker, T. J.; Boger, D. L. Fe(III)/NaBH4-mediated free radical hydrofluorination of unactivated alkenes J. Am. Chem. Soc. 2012, 134, 13588 13591
  46. 46
    Boger, D. L.; Brotherton, C. E. Total synthesis of azafluoranthene alkaloids: rufescine and imelutine J. Org. Chem. 1984, 49, 4050 4055
  47. 47
    Duflos, A.; Kruczynski, A.; Baret, J.-M. Novel aspects of natural and modified Vinca alkaloids Curr. Med. Chem., Anti-Cancer Agents 2002, 2, 55 75
  48. 48
    Campbell, E. L.; Skepper, C. K.; Sankar, K.; Duncan, K. K.; Boger, D. L. Transannular Diels–Alder/1,3-dipolar cycloaddition cascade of 1,3,4-oxadiazoles: total synthesis of a unique set of vinblastine analogues Org. Lett. 2013, 15, 5306 5309
  49. 49
    Roepke, J.; Salim, V.; Wu, M.; Thamm, A. M. K.; Murata, J.; Ploss, K.; Boland, W.; De Luca, V. Vinca drug components accumulate exclusively in leaf exudates of Madagascar periwinkle Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 15287 15292
  50. 50
    Once in a while you receive a valued gift if you ask the right question at the right time. Personal communication: Otis, Hutchinson, KS (1971) .

Cited By

ARTICLE SECTIONS
Jump To

This article is cited by 150 publications.

  1. Bowen Zhang, Frederik R. Erb, Aristidis Vasilopoulos, Eric A. Voight, Erik J. Alexanian. General Synthesis of N-Alkylindoles from N,N-Dialkylanilines via [4 + 1] Annulative Double C–H Functionalization. Journal of the American Chemical Society 2023, 145 (49) , 26540-26544. https://doi.org/10.1021/jacs.3c10751
  2. Luo-Rong Yuan, Shun-Jun Ji, Xiao-Ping Xu. Coupling-Spirocyclization Cascade of Tryptamine-Derived Isocyanides with Iodonium Ylides and Despirocyclization Reactions. Organic Letters 2023, 25 (43) , 7858-7862. https://doi.org/10.1021/acs.orglett.3c03090
  3. Rui-Han Niu, Jing Zhang, Ru-Yuan Zhao, Quan-Jian Luo, Jin-Heng Li, Bo Sun. Cobalt(III)-Catalyzed Directed C-7 Selective C–H Alkynylation of Indolines with Bromoalkynes. Organic Letters 2023, 25 (29) , 5411-5415. https://doi.org/10.1021/acs.orglett.3c01584
  4. Rimei Zheng, Aimin Xu, Tianyuan Zhang, Pei Li, Maoqing Shi, Shanliang Dong, Wenhao Hu, Yu Qian. Asymmetric Acyclic 1,3-Difunctionalization of Vinyl Carbenes via Site-Selective Vinylogous Mannich-Type Interception of Oxonium Ylides. Organic Letters 2023, 25 (29) , 5509-5514. https://doi.org/10.1021/acs.orglett.3c01983
  5. Assia Chebieb, Young Gyu Kim, Jin Kun Cha. Synthesis of Indoles from o-Haloanilines. The Journal of Organic Chemistry 2023, 88 (14) , 10164-10170. https://doi.org/10.1021/acs.joc.3c01047
  6. Cong Chen, Jing Chen, Han Wang, Ze-Feng Xu, Shengguo Duan, Chuan-Ying Li. Catalyst-Free Synthesis of Polycyclic Spiroindolines by Cascade Reaction of 3-(2-Isocyanoethyl)indoles with 1-Sulfonyl-1,2,3-triazoles. The Journal of Organic Chemistry 2023, 88 (13) , 9543-9553. https://doi.org/10.1021/acs.joc.3c00800
  7. Alexander W. Rand, Kevin J. Gonzalez, Christopher E. Reimann, Scott C. Virgil, Brian M. Stoltz. Total Synthesis of Strempeliopidine and Non-Natural Stereoisomers through a Convergent Petasis Borono–Mannich Reaction. Journal of the American Chemical Society 2023, 145 (13) , 7278-7287. https://doi.org/10.1021/jacs.2c13146
  8. Xiangji Yang, Kemiao Hong, Sujie Zhang, Zhijing Zhang, Su Zhou, Jingjing Huang, Xinfang Xu, Wenhao Hu. Asymmetric Three-Component Reaction of Two Diazo Compounds and Hyrdroxylamine Derivatives for the Access to Chiral α-Alkoxy-β-amino-carboxylates. ACS Catalysis 2022, 12 (19) , 12302-12309. https://doi.org/10.1021/acscatal.2c02541
  9. Wen-Bin Cao, Jian-Dong Zhang, Meng-Meng Xu, Hua-Wei Liu, Hai-Yan Li, Xiao-Ping Xu, Shun-Jun Ji. Syn-Stereoselective C3-Spirocyclization and C2-Amination of 3-(2-Isocyanoethyl)indole Using C,N-Cyclic Azomethine Imines. Organic Letters 2022, 24 (25) , 4620-4624. https://doi.org/10.1021/acs.orglett.2c01736
  10. Kristen M. Flynn, In-Soo Myeong, Taylor Pinto, Mohammad Movassaghi. Total Synthesis of (−)-Voacinol and (−)-Voacandimine C. Journal of the American Chemical Society 2022, 144 (20) , 9126-9131. https://doi.org/10.1021/jacs.2c03057
  11. Jiajun Zhang, Srinivas R. Paladugu, Rachel M. Gillard, Anindya Sarkar, Dale L. Boger. Tris(4-bromophenyl)aminium Hexachloroantimonate-Mediated Intermolecular C(sp2)–C(sp3) Free Radical Coupling of Vindoline with β-Ketoesters and Related Compounds. Journal of the American Chemical Society 2022, 144 (1) , 495-502. https://doi.org/10.1021/jacs.1c10971
  12. Hai-Jiao Long, Yin-Long Li, Bing-Qian Zhang, Wen-Ying Xiao, Xiao-Ying Zhang, Ling He, Jun Deng. Asymmetric Bromoaminocyclization and Desymmetrization of Cyclohexa-1,4-dienes through Anion Phase-Transfer Catalysis. Organic Letters 2021, 23 (21) , 8153-8157. https://doi.org/10.1021/acs.orglett.1c02817
  13. Fei Zhao, Jin Qiao, Yangbin Lu, Xiaoning Zhang, Long Dai, Siyu Liu, Hangcheng Ni, Xiuwen Jia, Xiaowei Wu, Shiyao Lu. Redox-Neutral Rhodium(III)-Catalyzed Chemospecific and Regiospecific [4+1] Annulation between Indoles and Alkenes for the Synthesis of Functionalized Imidazo[1,5-a]indoles. The Journal of Organic Chemistry 2021, 86 (15) , 10591-10607. https://doi.org/10.1021/acs.joc.1c01256
  14. Sharna-kay Daley, Geoffrey A. Cordell. Biologically Significant and Recently Isolated Alkaloids from Endophytic Fungi. Journal of Natural Products 2021, 84 (3) , 871-897. https://doi.org/10.1021/acs.jnatprod.0c01195
  15. Bijay Shrestha, Brennan T. Rose, Casey L. Olen, Aaron Roth, Adon C. Kwong, Yang Wang, Scott E. Denmark. A Unified Strategy for the Asymmetric Synthesis of Highly Substituted 1,2-Amino Alcohols Leading to Highly Substituted Bisoxazoline Ligands. The Journal of Organic Chemistry 2021, 86 (4) , 3490-3534. https://doi.org/10.1021/acs.joc.0c02899
  16. Christopher Gartshore, Shinji Tadano, Prem B. Chanda, Anindya Sarkar, Naidu S. Chowdari, Sanjeev Gangwar, Qian Zhang, Gregory D. Vite, Jelena Momirov, Dale L. Boger. Total Synthesis of Meayamycin and O-Acyl Analogues. Organic Letters 2020, 22 (21) , 8714-8719. https://doi.org/10.1021/acs.orglett.0c03308
  17. Anna E. Cholewczynski, Peyton C. Williams, Joshua G. Pierce. Stereocontrolled Synthesis of (±)-Melokhanine E via an Intramolecular Formal [3 + 2] Cycloaddition. Organic Letters 2020, 22 (2) , 714-717. https://doi.org/10.1021/acs.orglett.9b04546
  18. Byron A. Boon, Dale L. Boger. Triarylaminium Radical Cation Promoted Coupling of Catharanthine with Vindoline: Diastereospecific Synthesis of Anhydrovinblastine and Reaction Scope. Journal of the American Chemical Society 2019, 141 (36) , 14349-14355. https://doi.org/10.1021/jacs.9b06968
  19. Jiajun Zhang, Vyom Shukla, Dale L. Boger. Inverse Electron Demand Diels–Alder Reactions of Heterocyclic Azadienes, 1-Aza-1,3-Butadienes, Cyclopropenone Ketals, and Related Systems. A Retrospective. The Journal of Organic Chemistry 2019, 84 (15) , 9397-9445. https://doi.org/10.1021/acs.joc.9b00834
  20. Yongyan Zhu, Ruixuan Liu, Haoji Huang, Quanhong Zhu. Vinblastine-Loaded Nanoparticles with Enhanced Tumor-Targeting Efficiency and Decreasing Toxicity: Developed by One-Step Molecular Imprinting Process. Molecular Pharmaceutics 2019, 16 (6) , 2675-2689. https://doi.org/10.1021/acs.molpharmaceut.9b00243
  21. Deepali Waghray, Qinghai Zhang. Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment. Journal of Medicinal Chemistry 2018, 61 (12) , 5108-5121. https://doi.org/10.1021/acs.jmedchem.7b01457
  22. Christopher M. Glinkerman, Dale L. Boger. Synthesis, Characterization, and Rapid Cycloadditions of 5-Nitro-1,2,3-triazine. Organic Letters 2018, 20 (9) , 2628-2631. https://doi.org/10.1021/acs.orglett.8b00825
  23. Emma King-Smith, Christian R. Zwick, III, and Hans Renata . Applications of Oxygenases in the Chemoenzymatic Total Synthesis of Complex Natural Products. Biochemistry 2018, 57 (4) , 403-412. https://doi.org/10.1021/acs.biochem.7b00998
  24. Dale L. Boger . The Difference a Single Atom Can Make: Synthesis and Design at the Chemistry–Biology Interface. The Journal of Organic Chemistry 2017, 82 (23) , 11961-11980. https://doi.org/10.1021/acs.joc.7b02088
  25. Stephen F. Martin . Natural Products and Their Mimics as Targets of Opportunity for Discovery. The Journal of Organic Chemistry 2017, 82 (20) , 10757-10794. https://doi.org/10.1021/acs.joc.7b01368
  26. Joshua E. Zweig, Daria E. Kim, and Timothy R. Newhouse . Methods Utilizing First-Row Transition Metals in Natural Product Total Synthesis. Chemical Reviews 2017, 117 (18) , 11680-11752. https://doi.org/10.1021/acs.chemrev.6b00833
  27. John C. Lukesh, III, Daniel W. Carney, Huijun Dong, R. Matthew Cross, Vyom Shukla, Katharine K. Duncan, Shouliang Yang, Daniel M. Brody, Manuela M. Brütsch, Aleksandar Radakovic, and Dale L. Boger . Vinblastine 20′ Amides: Synthetic Analogues That Maintain or Improve Potency and Simultaneously Overcome Pgp-Derived Efflux and Resistance. Journal of Medicinal Chemistry 2017, 60 (17) , 7591-7604. https://doi.org/10.1021/acs.jmedchem.7b00958
  28. Nengzhong Wang, Shuo Du, Dong Li, and Xuefeng Jiang . Divergent Asymmetric Total Synthesis of (+)-Vincadifformine, (−)-Quebrachamine, (+)-Aspidospermidine, (−)-Aspidospermine, (−)-Pyrifolidine, and Related Natural Products. Organic Letters 2017, 19 (12) , 3167-3170. https://doi.org/10.1021/acs.orglett.7b01292
  29. Haosen Yuan, Zhixian Guo, and Tuoping Luo . Synthesis of (+)-Lysergol and Its Analogues To Assess Serotonin Receptor Activity. Organic Letters 2017, 19 (3) , 624-627. https://doi.org/10.1021/acs.orglett.6b03779
  30. Ming Yan, Julian C. Lo, Jacob T. Edwards, and Phil S. Baran . Radicals: Reactive Intermediates with Translational Potential. Journal of the American Chemical Society 2016, 138 (39) , 12692-12714. https://doi.org/10.1021/jacs.6b08856
  31. Steven W. M. Crossley, Carla Obradors, Ruben M. Martinez, and Ryan A. Shenvi . Mn-, Fe-, and Co-Catalyzed Radical Hydrofunctionalizations of Olefins. Chemical Reviews 2016, 116 (15) , 8912-9000. https://doi.org/10.1021/acs.chemrev.6b00334
  32. Oliver Allemann, Manuela Brutsch, John C. Lukesh III, Daniel M. Brody, and Dale L. Boger . Synthesis of a Potent Vinblastine: Rationally Designed Added Benign Complexity. Journal of the American Chemical Society 2016, 138 (27) , 8376-8379. https://doi.org/10.1021/jacs.6b04330
  33. Lorenzo V. White and Martin G. Banwell . Conversion of the Enzymatically Derived (1S,2S)-3-Bromocyclohexa-3,5-diene-1,2-diol into Enantiomerically Pure Compounds Embodying the Pentacyclic Framework of Vindoline. The Journal of Organic Chemistry 2016, 81 (4) , 1617-1626. https://doi.org/10.1021/acs.joc.5b02788
  34. Justin E. Sears and Dale L. Boger . Tandem Intramolecular Diels–Alder/1,3-Dipolar Cycloaddition Cascade of 1,3,4-Oxadiazoles: Initial Scope and Applications. Accounts of Chemical Research 2016, 49 (2) , 241-251. https://doi.org/10.1021/acs.accounts.5b00510
  35. Justin E. Sears, Timothy J. Barker, and Dale L. Boger . Total Synthesis of (−)-Vindoline and (+)-4-epi-Vindoline Based on a 1,3,4-Oxadiazole Tandem Intramolecular [4 + 2]/[3 + 2] Cycloaddition Cascade Initiated by an Allene Dienophile. Organic Letters 2015, 17 (21) , 5460-5463. https://doi.org/10.1021/acs.orglett.5b02818
  36. Takahiro Morikawa, Shinji Harada, and Atsushi Nishida . Chiral Holmium Complex-Catalyzed Synthesis of Hydrocarbazole from Siloxyvinylindole and Its Application to the Enantioselective Total Synthesis of (−)-Minovincine. The Journal of Organic Chemistry 2015, 80 (17) , 8859-8867. https://doi.org/10.1021/acs.joc.5b01393
  37. Maxence Holtz, Carlos G Acevedo-Rocha, Michael K Jensen. Combining enzyme and metabolic engineering for microbial supply of therapeutic phytochemicals. Current Opinion in Biotechnology 2024, 87 , 103110. https://doi.org/10.1016/j.copbio.2024.103110
  38. Tian-Shu Wu, Yong-Jiu Hao, Zhong-Jian Cai, Shun-Jun Ji. Ligand-controlled regioselective cascade C–C/C–F cleavage/annulation of gem -DFCPs: a divergent synthesis of pyrroles. Organic Chemistry Frontiers 2024, 11 (4) , 1057-1061. https://doi.org/10.1039/D3QO01879B
  39. Jing Zhang, Quan‐Jian Luo, Han‐Chi Wang, Jin‐Heng Li, Bo Sun. Ru( II )‐Catalyzed ortho C—H Allylation of N ‐Aryl ‐7‐azaindoles with 2‐Methylidene Cyclic Carbonate. Chinese Journal of Chemistry 2024, 46 https://doi.org/10.1002/cjoc.202300627
  40. Rachel M. Gillard, Jiajun Zhang, Richard Steel, Jocelyn Wang, Jessica L. Strull, Bin Cai, Nilanjana Chakraborty, Dale L. Boger. Aryl Annulation: A Powerful Simplifying Retrosynthetic Disconnection. Synthesis 2024, 56 (01) , 118-133. https://doi.org/10.1055/a-1959-2088
  41. Rahul Shukla, Ajit Singh, Kamalinder K. Singh. Vincristine-based nanoformulations: a preclinical and clinical studies overview. Drug Delivery and Translational Research 2024, 14 (1) , 1-16. https://doi.org/10.1007/s13346-023-01389-6
  42. Shohreh Bakhshi, Alireza Shoari, Parisa Alibolandi, Mahmoud Ganji, Esraa Ghazy, Abbas Rahdar, Sonia Fathi-karkan, Sadanand Pandey. Emerging innovations in vincristine-encapsulated nanoparticles: Pioneering a new era in oncological therapeutics. Journal of Drug Delivery Science and Technology 2024, 91 , 105270. https://doi.org/10.1016/j.jddst.2023.105270
  43. P. K. Pournami, Nasheeda Rasheed, Athira Raveendran, Vipin Gopinath. Antineoplastic Drug Leads from Plants and Microbes. 2024, 287-331. https://doi.org/10.1007/978-981-99-9183-9_12
  44. Chong Qiu, Jun Zhe Zhang, Bo Wu, Cheng Chao Xu, Huan Huan Pang, Qing Chao Tu, Yu Qian Lu, Qiu Yan Guo, Fei Xia, Ji Gang Wang. Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines. Journal of Nanobiotechnology 2023, 21 (1) https://doi.org/10.1186/s12951-023-02165-x
  45. Hong Zhang, Cui-Ping Li, Li-Li Wang, Zhuo-Da Zhou, Li Wen-Sen, Ling-Yi Kong, Yang Ming-Hua. Asperochones A and B, two antimicrobial aromatic polyketides from the endophytic fungus Aspergillus sp. MMC-2. Chinese Chemical Letters 2023, 82 , 109351. https://doi.org/10.1016/j.cclet.2023.109351
  46. Firdoos Ahmad Sofi, Nahida Tabassum. Natural product inspired leads in the discovery of anticancer agents: an update. Journal of Biomolecular Structure and Dynamics 2023, 41 (17) , 8605-8628. https://doi.org/10.1080/07391102.2022.2134212
  47. Ameer Fawad Zahoor, Sadaf Saeed, Azhar Rasul, Razia Noreen, Ali Irfan, Sajjad Ahmad, Shah Faisal, Sami A. Al-Hussain, Muhammad Athar Saeed, Muhammed Tilahun Muhammed, Zeinab A. Muhammad, Magdi E. A. Zaki. Synthesis, Cytotoxic, and Computational Screening of Some Novel Indole–1,2,4-Triazole-Based S-Alkylated N-Aryl Acetamides. Biomedicines 2023, 11 (11) , 3078. https://doi.org/10.3390/biomedicines11113078
  48. Anjali Gupta, Joydev K. Laha. Growing Utilization of Radical Chemistry in the Synthesis of Pharmaceuticals. The Chemical Record 2023, 23 (11) https://doi.org/10.1002/tcr.202300207
  49. Roland Wohlgemuth. Synthesis of Metabolites and Metabolite-like Compounds Using Biocatalytic Systems. Metabolites 2023, 13 (10) , 1097. https://doi.org/10.3390/metabo13101097
  50. Hui Xu, Yanfeng Dang. Unveiling the mechanism and origin of stereocontrol in dinuclear-zinc-catalyzed reductive desymmetrization of malonic esters. Organic Chemistry Frontiers 2023, 10 (18) , 4529-4541. https://doi.org/10.1039/D3QO00846K
  51. Ju Hee Kim, Sun A Lee, Tae Sik Jeon, Jin Kun Cha, Young Gyu Kim. A Unified Approach to Mono- and 2,3-Disubstituted N–H Indoles. Synlett 2023, 34 (14) , 1719-1722. https://doi.org/10.1055/s-0042-1752656
  52. Rishabha Malviya, Arun Kumar Singh, Deepika Yadav. Novel Strategies Preventing Emergence of MDR in Breast Cancer. 2023, 171-194. https://doi.org/10.1002/9781394209866.ch9
  53. Ramsha Munir, Ameer Fawad Zahoor, Sadia Javed, Bushra Parveen, Asim Mansha, Ahmad Irfan, Samreen Gul Khan, Ali Irfan, Katarzyna Kotwica-Mojzych, Mariusz Mojzych. Simmons–Smith Cyclopropanation: A Multifaceted Synthetic Protocol toward the Synthesis of Natural Products and Drugs: A Review. Molecules 2023, 28 (15) , 5651. https://doi.org/10.3390/molecules28155651
  54. Fuzhuo Li, Heping Deng, Hans Renata. Chemoenzymatic approaches for exploring structure–activity relationship studies of bioactive natural products. Nature Synthesis 2023, 2 (8) , 708-718. https://doi.org/10.1038/s44160-023-00358-8
  55. Kolawole Olofinsan, Heidi Abrahamse, Blassan P. George. Therapeutic Role of Alkaloids and Alkaloid Derivatives in Cancer Management. Molecules 2023, 28 (14) , 5578. https://doi.org/10.3390/molecules28145578
  56. Derek A. Leas, Daniel C. Schultz, Robert W. Huigens III. Chemical Reactions of Indole Alkaloids That Enable Rapid Access to New Scaffolds for Discovery. SynOpen 2023, 07 (02) , 165-185. https://doi.org/10.1055/a-2048-8412
  57. Shuai Jiang, Yu-Xin Huang, Xiao-Feng Wang, Xiao-Ping Xu, Shun-Jun Ji. Radical addition/spirocyclization cascade of tryptamine-derived isocyanides with aryl boronic acids: efficient access to spiroindoline derivatives. Organic Chemistry Frontiers 2023, 10 (7) , 1660-1668. https://doi.org/10.1039/D2QO01992B
  58. Xuefei Chen, Chao Huang, Kunlun Li, Junqiu Liu, Youyou Zheng, Yue Feng, Guo-yin Kai. Recent advances in biosynthesis and pharmacology of β-elemene. Phytochemistry Reviews 2023, 22 (1) , 169-186. https://doi.org/10.1007/s11101-022-09833-0
  59. Chhanda Charan Danta, Alakh Niranjan Sahu. Naturally occurring anticancer drugs. 2023, 539-588. https://doi.org/10.1016/B978-0-323-90575-6.00017-X
  60. Jun‐Xiong He, Xu‐Ge Si, Qi‐Tao Lu, Qian‐Wei Zhang, Quan Cai. An Enantioselective Approach to Heteroatom‐Containing Bicyclic Derivatives via Inverse‐Electron‐Demand Diels−Alder Reactions. Chinese Journal of Chemistry 2023, 41 (1) , 21-26. https://doi.org/10.1002/cjoc.202200441
  61. Mehdi Eshraghi, Mazaher Ahmadi, Saeid Afshar, Shahrokh Lorzadeh, Aida Adlimoghaddam, Nahid Rezvani Jalal, Ryan West, Sanaz Dastghaib, Somayeh Igder, Seyed Reza Naeimi Torshizi, Amir Mahmoodzadeh, Pooneh Mokarram, Tayyebeh Madrakian, Benedict C. Albensi, Marek J. Łos, Saeid Ghavami, Stevan Pecic. Enhancing autophagy in Alzheimer's disease through drug repositioning. Pharmacology & Therapeutics 2022, 237 , 108171. https://doi.org/10.1016/j.pharmthera.2022.108171
  62. Pei Dong, Zhaojing Li, Xiaohua Liu, Shunxi Dong, Xiaoming Feng. Asymmetric synthesis of polycyclic spiroindolines via the Dy-catalyzed cascade reaction of 3-(2-isocyanoethyl)indoles with aziridines. Organic Chemistry Frontiers 2022, 9 (17) , 4591-4597. https://doi.org/10.1039/D2QO00874B
  63. Liu‐Peng Zhao, Peng‐Juan Li, Lijia Wang, Yong Tang. Allenamide‐Initiated Cascade [2+2+2] Annulation Enabling the Divergent Total Synthesis of (−)‐Deoxoapodine, (−)‐Kopsifoline D and (±)‐Melotenine A. Angewandte Chemie International Edition 2022, 61 (34) https://doi.org/10.1002/anie.202207360
  64. Liu‐Peng Zhao, Peng‐Juan Li, Lijia Wang, Yong Tang. Allenamide‐Initiated Cascade [2+2+2] Annulation Enabling the Divergent Total Synthesis of (−)‐Deoxoapodine, (−)‐Kopsifoline D and (±)‐Melotenine A. Angewandte Chemie 2022, 134 (34) https://doi.org/10.1002/ange.202207360
  65. Gautier Bourbon, Ritchy Leroy, Carine Machado-Rodrigues, Georges Massiot. Catharanthine borane – An unexpected reaction product. Phytochemistry Letters 2022, 48 , 40-42. https://doi.org/10.1016/j.phytol.2022.01.009
  66. Dan Long, Gaoyuan Zhao, Zhiqiang Liu, Peiqi Chen, Shiqiang Ma, Xingang Xie, Xuegong She. Enantioselective Pictet–Spengler Condensation to Access the Total Synthesis of (+)‐Tabertinggine. European Journal of Organic Chemistry 2022, 2022 (10) https://doi.org/10.1002/ejoc.202200088
  67. Yan-Bo Zheng, Yan-Qun Dong, Shu-Yi Si, Yong-Su Zhen, Jian-Hua Gong. IMB5476, a novel microtubule inhibitor, induces mitotic catastrophe and overcomes multidrug resistance in tumors. European Journal of Pharmacology 2022, 919 , 174802. https://doi.org/10.1016/j.ejphar.2022.174802
  68. Xiao‐Tong Lin, Cheng Zhao, Da‐Ru Wang, Guang‐Cheng Wu, Guo‐Shu Chen, Shu‐Jie Chen, Hai Ren, Dong‐Sheng Deng, Yi‐Bing Xu, Xiao‐Wei Hu, Yun‐Lin Liu. BiCl 3 ‐Mediated Tandem Cyclization of Tryptamine‐Derived Ynamide: Concise Synthesis of Pentacyclic Spiroindolines and Tricyclic Indole Derivatives. Advanced Synthesis & Catalysis 2022, 364 (4) , 890-896. https://doi.org/10.1002/adsc.202101232
  69. Gen Li, Mingliang Lou, Xiangbing Qi. A brief overview of classical natural product drug synthesis and bioactivity. Organic Chemistry Frontiers 2022, 9 (2) , 517-571. https://doi.org/10.1039/D1QO01341F
  70. Jinfeng Kang, Todd R. Lewis, Alex Gardner, Rodrigo B. Andrade, Rongsheng E. Wang. Semi-syntheses and interrogation of indole-substituted Aspidosperma terpenoid alkaloids. Organic & Biomolecular Chemistry 2022, 177 https://doi.org/10.1039/D2OB00610C
  71. Xiangkai Kong, Yipeng Zhang, Lingjing Dang, Wen Chen, Hongbin Zhang. Research Progress in Synthesis of Indole Alkaloids Vindoline and Vindorosine. Chinese Journal of Organic Chemistry 2022, 42 (9) , 2728. https://doi.org/10.6023/cjoc202204009
  72. Jinghua Wu, Zhiqiang Ma. Metal-hydride hydrogen atom transfer (MHAT) reactions in natural product synthesis. Organic Chemistry Frontiers 2021, 8 (24) , 7050-7076. https://doi.org/10.1039/D1QO01139A
  73. Haizhen Li, Jinyu Wu, Jianfeng Zheng, Wei-Dong Z. Li. Synthesis of polycyclic spiroindolines via the cascade reaction of 3-(2-isocyanoethyl)indoles. Chemical Communications 2021, 57 (84) , 11092-11095. https://doi.org/10.1039/D1CC04576H
  74. Shi Tang, Shumin Ding, Dan Li, Lianjie Li, Haixia Zhao, Minxue Chai, Jian Wang. Palladium-catalysed imidoylative spirocyclization of 3-(2-isocyanoethyl)indoles. Chemical Communications 2021, 57 (81) , 10576-10579. https://doi.org/10.1039/D1CC03240B
  75. Fei Zhao, Jing Chen, Jin Qiao, Yangbin Lu, Xiaoning Zhang, Hui Mao, Shiyao Lu, Xin Gong, Siyu Liu, Xiaowei Wu, Long Dai. Chemo‐ and Regioselective Synthesis of Functionalized 1 H ‐imidazo[1,5‐ a ]indol‐3(2 H )‐ones via a Redox‐Neutral Rhodium(III)‐Catalyzed [4+1] Annulation between Indoles and Alkynes. Advanced Synthesis & Catalysis 2021, 363 (18) , 4380-4389. https://doi.org/10.1002/adsc.202100555
  76. Yulei Zhao, Shuai Li, Yuhang Fan, Xuqiang Guo, Xin Jiao, Laijin Tian, Xuejun Sun. Synthesis of 10 H ‐Indolo[1,2‐ a ]indole Derivatives via Intramolecular Cycloaddition and H‐Migration. European Journal of Organic Chemistry 2021, 2021 (30) , 4358-4363. https://doi.org/10.1002/ejoc.202100723
  77. Camillo La Mesa, Oliarinony Ranalison, Lovasoa N. Randriantseheno, Gianfranco Risuleo. Natural Products from Madagascar, Socio-Cultural Usage, and Potential Applications in Advanced Biomedicine: A Concise Review. Molecules 2021, 26 (15) , 4507. https://doi.org/10.3390/molecules26154507
  78. Matokah M. Abualnaja, Joseph Cowell, John D. Jolliffe, Corinne Wills, Paul G. Waddell, William Clegg, Michael J. Hall. Diastereoselective rearomative etherifications and aminations of 2,3,9,9a-tetrahydro-1H-carbazoles. Tetrahedron 2021, 89 , 132144. https://doi.org/10.1016/j.tet.2021.132144
  79. Byron A. Boon, Yi-Yun Yu, Dale L. Boger. Total synthesis of (−)-4-desacetoxy-1-oxovindoline: Single atom exchange of an embedded core heteroatom in vindoline. Tetrahedron 2021, 87 , 132117. https://doi.org/10.1016/j.tet.2021.132117
  80. The Hong Phong Nguyen, V. Bharath Kumar, Vinoth Kumar Ponnusamy, Thi Thu Thao Mai, Phuong Tran Nhat, Kathirvel Brindhadevi, Arivalagan Pugazhendhi. Phytochemicals intended for anticancer effects at preclinical levels to clinical practice: Assessment of formulations at nanoscale for non-small cell lung cancer (NSCLC) therapy. Process Biochemistry 2021, 104 , 55-75. https://doi.org/10.1016/j.procbio.2021.02.004
  81. Mallory Pullman, Francisco León, Stephen J. Cutler. Natural Products as Cytotoxic Agents. 2021, 1-89. https://doi.org/10.1002/0471266949.bmc216.pub2
  82. Sebastián J. Castro, José M. Padrón, Benjamin Darses, Viviana E. Nicotra, Philippe Dauban. Late‐stage Rh(II)‐catalyzed Nitrene Transfer for the Synthesis of Guaianolide Analogs with Enhanced Antiproliferative Activity. European Journal of Organic Chemistry 2021, 2021 (12) , 1859-1863. https://doi.org/10.1002/ejoc.202100074
  83. Jiawei Sun, He Yang, Wenjun Tang. Recent advances in total syntheses of complex dimeric natural products. Chemical Society Reviews 2021, 50 (4) , 2320-2336. https://doi.org/10.1039/D0CS00220H
  84. Pham T. Tham, Pham T. Chinh, Nguyen V. Tuyen, Duong N. Bang, Dinh T. Van, Vu T. Kien, Hoang T. Thanh, Duong H. Quynh, Vu D. Cuong, Nguyen H. Thanh, Alfonso Pérez-Encabo. Synthesis and cytotoxic evaluation of novel simplified plinabulin-quinoline derivatives. Mendeleev Communications 2021, 31 (2) , 213-215. https://doi.org/10.1016/j.mencom.2021.03.022
  85. Bruno Musquiari, Eduardo J. Crevelin, Bianca W. Bertoni, Suzelei de C. França, Ana Maria S. Pereira, Ana Carolina Devides Castello, Willian O. Castillo-Ordoñez, Silvana Giuliatti, Adriana A. Lopes. Precursor-directed Biosynthesis in Tabernaemontana catharinensis as a New Avenue for Alzheimerʼs Disease-modifying Agents. Planta Medica 2021, 87 (01/02) , 136-147. https://doi.org/10.1055/a-1315-2282
  86. Mahesh H. Shinde, Chepuri V. Ramana. An Apparent Umpolung Reactivity of Indole through [Au]‐Catalysed Cyclisation and Lewis‐Acid‐Mediated Allylation. Chemistry – A European Journal 2020, 26 (71) , 17171-17175. https://doi.org/10.1002/chem.202003441
  87. Zhi-Chen Wu, Dale L. Boger. The quest for supernatural products: the impact of total synthesis in complex natural products medicinal chemistry. Natural Product Reports 2020, 37 (11) , 1511-1531. https://doi.org/10.1039/D0NP00060D
  88. Fei Wang, Juan Li, Shengjie Fan, Zhigang Jin, Cheng Huang. Targeting stress granules: A novel therapeutic strategy for human diseases. Pharmacological Research 2020, 161 , 105143. https://doi.org/10.1016/j.phrs.2020.105143
  89. Samuel A. Bradley, Jie Zhang, Michael K. Jensen. Deploying Microbial Synthesis for Halogenating and Diversifying Medicinal Alkaloid Scaffolds. Frontiers in Bioengineering and Biotechnology 2020, 8 https://doi.org/10.3389/fbioe.2020.594126
  90. Lucie Cahlíková, Marcela Šafratová, Anna Hošťálková, Jakub Chlebek, Daniela Hulcová, Kateřina Breiterová, Lubomír Opletal. Pharmacognosy and Its Role in the System of Profile Disciplines in Pharmacy. Natural Product Communications 2020, 15 (9) , 1934578X2094545. https://doi.org/10.1177/1934578X20945450
  91. Xiaowei Wu, Pinyi Li, Yangbin Lu, Jin Qiao, Jingwei Zhao, Xiuwen Jia, Hangcheng Ni, Lichun Kong, Xiaoning Zhang, Fei Zhao. Rhodium‐Catalyzed Cascade Reactions of Indoles with 4‐Hydroxy‐2‐Alkynoates for the Synthesis of Indole‐Fused Polyheterocycles. Advanced Synthesis & Catalysis 2020, 362 (14) , 2953-2960. https://doi.org/10.1002/adsc.202000493
  92. Timothy Barker. Ferric Oxalate Hexahydrate. 2020, 1-4. https://doi.org/10.1002/047084289X.rn02346
  93. Guo‐Shu Chen, Shu‐Jie Chen, Jian Luo, Xiang‐Yu Mao, Albert Sun‐Chi Chan, Raymond Wai‐Yin Sun, Yun‐Lin Liu. Tandem Cross‐Coupling/Spirocyclization/Mannich‐Type Reactions of 3‐(2‐Isocyanoethyl)indoles with Diazo Compounds toward Polycyclic Spiroindolines. Angewandte Chemie 2020, 132 (2) , 624-631. https://doi.org/10.1002/ange.201911614
  94. Guo‐Shu Chen, Shu‐Jie Chen, Jian Luo, Xiang‐Yu Mao, Albert Sun‐Chi Chan, Raymond Wai‐Yin Sun, Yun‐Lin Liu. Tandem Cross‐Coupling/Spirocyclization/Mannich‐Type Reactions of 3‐(2‐Isocyanoethyl)indoles with Diazo Compounds toward Polycyclic Spiroindolines. Angewandte Chemie International Edition 2020, 59 (2) , 614-621. https://doi.org/10.1002/anie.201911614
  95. Junpei Matsuoka. Introduction. 2020, 1-18. https://doi.org/10.1007/978-981-15-8652-1_1
  96. Khoa Chung, Sarah E. O'Connor. Biosynthesis of Vinblastine. 2020, 642-685. https://doi.org/10.1016/B978-0-12-409547-2.14618-9
  97. M. Toufiqur Rahman, James M. Cook. The C-19 methyl substituted sarpagine-macroline-ajmaline alkaloids: Diversity, occurrence, bioactivity, and synthesis. 2020, 1-57. https://doi.org/10.1016/B978-0-12-817903-1.00001-2
  98. Adriana A. Lopes, Bianca Chioca, Bruno Musquiari, Eduardo J. Crevelin, Suzelei de C. França, Maria Fatima das G. Fernandes da Silva, Ana Maria S. Pereira. Unnatural spirocyclic oxindole alkaloids biosynthesis in Uncaria guianensis. Scientific Reports 2019, 9 (1) https://doi.org/10.1038/s41598-019-47706-3
  99. Ryan A. Shenvi, Jeishla L. M. Matos, Samantha A. Green. Hydrofunctionalization of Alkenes by Hydrogen‐Atom Transfer. 2019, 383-470. https://doi.org/10.1002/0471264180.or100.07
  100. Verrill M. Norwood, Robert W. Huigens. Harnessing the Chemistry of the Indole Heterocycle to Drive Discoveries in Biology and Medicine. ChemBioChem 2019, 20 (18) , 2273-2297. https://doi.org/10.1002/cbic.201800768
Load all citations
  • Abstract

    Figure 1

    Figure 1. Natural product structures.

    Figure 2

    Figure 2. Key cycloaddition cascade.

    Figure 3

    Figure 3. First generation total synthesis of vinblastine.

    Figure 4

    Figure 4. Key elements of the asymmetric total synthesis approaches.

    Figure 5

    Figure 5. Single-step coupling and in situ oxidation and representative vinblastine analogues prepared by total synthesis.

    Figure 6

    Figure 6. Probing the importance of the C5 ethyl group.

    Scheme 1

    Figure 7

    Figure 7. 10′-Fluorovinblastine and 10′-fluorovincristine.

    Figure 8

    Figure 8. Space filling model of the 10′-fluoro binding site of 10′-fluorovinblastine (R = F, top) generated by adding the fluorine substituent to the X-ray structure of tubulin-bound vinblastine (43) (R = H, bottom). (40) Comparison models where R = Cl, Br, and I illustrated the unique fit for F, and the complexes exhibited increasingly larger destabilizing steric interactions as the substituent size progressively increased.

    Figure 9

    Figure 9. 10′-Fluorovinblastine human tumor cell growth inhibition.

    Scheme 2

    Figure 10

    Figure 10. Hydrogen atom transfer (HAT) free radical oxidation of anhydrovinblastine and generalization of the methodology for unactivated alkene functionalization.

    Figure 11

    Figure 11. (top) Initial C20′ vinblastine analogues. (bottom) X-ray structure (43) of vinblastine bound to tubulin highlighting the region surrounding vinblastine C20′ site.

    Figure 12

    Figure 12. Disubstituted C20′ urea derivatives of vinblastine.

    Scheme 3

  • References

    ARTICLE SECTIONS
    Jump To

    This article references 50 other publications.

    1. 1
      Noble, R. L.; Beer, C. T.; Cutts, J. H. Role of chance observations in chemotherapy: Vinca rosea Ann. N.Y. Acad. Sci. 1958, 76, 882 894
    2. 2
      Noble, R. L. Catharanthus roseus (vinca rosea): Importance and value of a chance observation Lloydia 1964, 27, 280 281
    3. 3
      Svoboda, G. H.; Nuess, N.; Gorman, M. Alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don.). V. Preparation and characterization of alkaloids J. Am. Pharm. Assoc. Sci. Ed. 1959, 48, 659 666
    4. 4
      Neuss, N.; Neuss, M. N. Therapeutic use of bisindole alkaloids from catharanthus. In The Alkaloids; Brossi, A.; Suffness, M., Eds.; Academic: San Diego, CA, 1990; Vol. 37, pp 229 240.
    5. 5
      Pearce, H. L. Medicinal chemistry of bisindole alkaloids from Catharanthus. In The Alkaloids; Brossi, A.; Suffness, M., Eds.; Academic: San Diego, CA, 1990; Vol. 37, pp 145 204.
    6. 6
      Kuehne, M. E.; Marko, I. Syntheses of vinblastine-type alkaloids. In The Alkaloids; Brossi, A.; Suffness, M., Eds.; Academic: San Diego, CA, 1990; Vol. 37, pp 77 132.
    7. 7
      Fahy, J. Modifications in the “upper” velbenamine part of the Vinca alkaloids have major implications for tubulin interacting activities Curr. Pharm. Des. 2001, 7, 1181 1197
    8. 8
      Potier, P. Synthesis of the antitumor dimeric indole alkaloids from catharanthus species (vinblastine group) J. Nat. Prod. 1980, 43, 72 86
    9. 9
      Kutney, J. P. Plant cell culture combined with chemistry: a powerful route to complex natural products Acc. Chem. Res. 1993, 26, 559 566
    10. 10
      Langlois, N.; Gueritte, F.; Langlois, Y.; Potier, P. Application of a modification of the Polonovski reaction to the synthesis of vinblastine-type alkaloids J. Am. Chem. Soc. 1976, 98, 7017 7024
    11. 11
      Kutney, J. P.; Hibino, T.; Jahngen, E.; Okutani, T.; Ratcliffe, A. H.; Treasurywala, A. M.; Wunderly, S. Total synthesis of indole and dihydroindole alkaloids. IX. Studies on the synthesis of bisindole alkaloids in the vinblastine-vincristine series. The biogenetic approach Helv. Chim. Acta 1976, 59, 2858 2882
    12. 12
      Kuehne, M. E.; Matson, P. A.; Bornmann, W. G. Enantioselective syntheses of vinblastine, leurosidine, vincovaline and 20′-epi-vincovaline J. Org. Chem. 1991, 56, 513 528
    13. 13
      Bornmann, W. G.; Kuehne, M. E. A common intermediate providing syntheses of ψ-tabersonine, coronaridine, iboxyphylline, ibophyllidine, vinamidine, and vinblastine J. Org. Chem. 1992, 57, 1752 1760
    14. 14
      Yokoshima, S.; Ueda, T.; Kobayashi, S.; Sato, A.; Kuboyama, T.; Tokuyama, H.; Fukuyama, T. Stereocontrolled total synthesis of (+)-vinblastine J. Am. Chem. Soc. 2002, 124, 2137 2139

      Additionally, see:

      Kuboyama, T.; Yokoshima, S.; Tokuyama, H.; Fukuyama, T. Stereocontrolled total synthesis of (+)-vincristine Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 11966 11970
    15. 15
      Magnus, P.; Stamford, A.; Ladlow, M. Synthesis of the antitumor bisindole alkaloid vinblastine: diastereoselectivity and solvent effect on the stereochemistry of the crucial C-15-C-18′ bond J. Am. Chem. Soc. 1990, 112, 8210 8212
    16. 16
      Ishikawa, H.; Colby, D. A.; Seto, S.; Va, P.; Tam, A.; Kakei, H.; Rayl, T. J.; Hwang, I.; Boger, D. L. Total synthesis of vinblastine, vincristine, related natural products, and key structural analogues J. Am. Chem. Soc. 2009, 131, 4904 4916
    17. 17
      Ishikawa, H.; Elliott, G. I.; Velcicky, J.; Choi, Y.; Boger, D. L. Total synthesis of (−)- and ent-(+)-vindoline and related alkaloids J. Am. Chem. Soc. 2006, 128, 10596 10612
    18. 18
      Choi, Y.; Ishikawa, H.; Velcicky, J.; Elliott, G. I.; Miller, M. M.; Boger, D. L. Total synthesis of (−)- and ent-(+)-vindoline Org. Lett. 2005, 7, 4539 4542
    19. 19
      Yuan, Z.; Ishikawa, H.; Boger, D. L. Total synthesis of natural (−)- and ent-(+)-4-desacetoxy-6,7-dihydrovindorosine and natural and ent-minovine: oxadiazole tandem intramolecular Diels–Alder/1,3-dipolar cycloaddition reaction Org. Lett. 2005, 7, 741 744
    20. 20
      Elliott, G. I.; Velcicky, J.; Ishikawa, H.; Li, Y.; Boger, D. L. Total synthesis of (−)- and ent-(+)-vindorosine: tandem intramolecular Diels–Alder/1,3-dipolar cycloaddition reaction of 1,3,4-oxadiazoles Angew. Chem., Int. Ed. 2006, 45, 620 622
    21. 21
      Ishikawa, H.; Boger, D. L. Total synthesis of natural (−)- and ent-(+)-4-desacetoxy-5-desethylvindoline Heterocycles 2007, 72, 95 102
    22. 22
      Elliott, G. I.; Fuchs, J. R.; Blagg, B. S. J.; Ishikawa, H.; Tao, H.; Yuan, Z.; Boger, D. L. Intramolecular Diels–Alder/1,3-dipolar cycloaddition cascade of 1,3,4-oxadiazoles J. Am. Chem. Soc. 2006, 128, 10589 10595
    23. 23
      Wilkie, G. D.; Elliott, G. I.; Blagg, B. S. J.; Wolkenberg, S. E.; Soenen, D. B.; Miller, M. M.; Pollack, S.; Boger, D. L. Intramolecular Diels–Alder and tandem intramolecular Diels–Alder/1,3-dipolar cycloaddition reactions of 1,3,4-oxadiazoles J. Am. Chem. Soc. 2002, 124, 11292 11294
    24. 24
      Boger, D. L. Diels–Alder reactions of azadienes Tetrahedron 1983, 39, 2869 2939
    25. 25
      Boger, D. L. Diels–Alder reactions of heterocyclic azadienes Chem. Rev. 1986, 86, 781 793
    26. 26
      Vukovic, J.; Goodbody, A. E.; Kutney, J. P.; Misawa, M. Production of 3′,4′-anhydrovinblastine: a unique chemical synthesis Tetrahedron 1988, 44, 325 331
    27. 27
      Ishikawa, H.; Colby, D. A.; Boger, D. L. Direct coupling of catharanthine and vindoline to provide vinblastine: total synthesis of (+)- and ent-(−)-vinblastine J. Am. Chem. Soc. 2008, 130, 420 421
    28. 28
      Sasaki, Y.; Kato, D.; Boger, D. L. Asymmetric total synthesis of vindorosine, vindoline, and key vinblastine analogues J. Am. Chem. Soc. 2010, 132, 13533 13544
    29. 29
      Kato, D.; Sasaki, Y.; Boger, D. L. Asymmetric total synthesis of vindoline J. Am. Chem. Soc. 2010, 132, 3685 3687
    30. 30
      Kuehne, M. E.; Bornmann, W. G.; Marko, I.; Qin, Y.; Le Boulluec, K. L.; Frasier, D. A.; Xu, F.; Malamba, T.; Ensinger, C. L.; Borman, L. S.; Huot, A. E.; Exon, C.; Bizzarro, F. T.; Cheung, J. B.; Bane, S. L. Syntheses and biological evaluation of vinblastine congeners Org. Biomol. Chem. 2003, 1, 2120 2136
    31. 31
      Miyazaki, T.; Yokoshima, S.; Simizu, S.; Osada, H.; Tokuyama, H.; Fukuyama, T. Synthesis of (+)-vinblastine and its analogues Org. Lett. 2007, 9, 4737 4740
    32. 32
      Voss, M. E.; Ralph, J. M.; Xie, D.; Manning, D. D.; Chen, X.; Frank, A. J.; Leyhane, A. J.; Liu, L.; Stevens, J. M.; Budde, C.; Surman, M. D.; Friedrich, T.; Peace, D.; Scott, I. L.; Wolf, M.; Johnson, R. Synthesis and SAR of vinca alkaloid analogues Bioorg. Med. Chem. Lett. 2009, 19, 1245 1249
    33. 33
      Gherbovet, O.; Coderch, C.; Alvarez, M. C. G.; Bignon, J.; Thoret, S.; Martin, M.-T.; Guéritte, F.; Gago, F.; Roussi, F. Synthesis and biological evaluation of a new series of highly functionalized 7′-homo-anhydrovinblastine derivatives J. Med. Chem. 2013, 56, 6088 6100
    34. 34
      Va, P.; Campbell, E. L.; Robertson, W. M.; Boger, D. L. Total synthesis and evaluation of a key series of C5-substituted vinblastine derivatives J. Am. Chem. Soc. 2010, 132, 8489 8495
    35. 35
      Schleicher, K. D.; Sasaki, Y.; Tam, A.; Kato, D.; Duncan, K. K.; Boger, D. L. Total synthesis and evaluation of vinblastine analogues containing systematic deep-seated modifications in the vindoline subunit ring system: core redesign J. Med. Chem. 2013, 56, 483 495
    36. 36
      Leggans, E. K.; Barker, T. J.; Duncan, K. K.; Boger, D. L. Iron(III)/NaBH4-mediated additions to unactivated alkenes: synthesis of novel 20′-vinblastine analogues Org. Lett. 2012, 14, 1428 1431
    37. 37
      Leggans, E. K.; Duncan, K. K.; Barker, T. J.; Schleicher, K. D.; Boger, D. L. A remarkable series of vinblastine analogues displaying enhanced activity and an unprecedented tubulin binding steric tolerance: C20′ urea derivatives J. Med. Chem. 2013, 56, 628 639
    38. 38
      Barker, T. J.; Duncan, K. K.; Otrubova, K.; Boger, D. L. Potent vinblastine C20′ ureas displaying additionally improved activity against a vinblastine-resistant cancer cell line ACS Med. Chem. Lett. 2013, 4, 985 988
    39. 39
      Tam, A.; Gotoh, H.; Robertson, W. M.; Boger, D. L. Catharanthine C16 substituent effects on the biomimetic coupling with vindoline: preparation and evaluation of a key series of vinblastine analogues Bioorg. Med. Chem. Lett. 2010, 20, 6408 6410
    40. 40
      Gotoh, H.; Duncan, K. K.; Robertson, W. M.; Boger, D. L. 10′-Fluorovinblastine and 10′-fluorovincristine: synthesis of a key series of modified Vinca alkaloids ACS Med. Chem. Lett. 2011, 2, 948 952
    41. 41
      Gotoh, H.; Sears, J. E.; Eschenmoser, A.; Boger, D. L. New insights into the mechanism and an expanded scope of the Fe(III)-mediated vinblastine coupling reaction J. Am. Chem. Soc. 2012, 134, 13240 13243
    42. 42

      We thank Gregory Vite and Robert Borzilleri for arranging and overseeing this assessment and Craig Fairchild, Kathy Johnson, and Russell Peterson for conducting the testing at Bristol–Myers Squibb.

    43. 43
      Gigant, B.; Wang, C.; Ravelli, R. B. G.; Roussi, F.; Steinmetz, M. O.; Curmi, P. A.; Sobel, A.; Knossow, M. Structural basis for the regulation of tublin by vinblastine Nature 2005, 435, 519 522
    44. 44
      Iwasaki, K.; Wan, K. K.; Oppedisano, A.; Crossley, S. W. M.; Shenvi, R. A. Simple, chemoselective hydrogenation with thermodynamic stereocontrol J. Am. Chem. Soc. 2014, 136, 1300 1303

      Also see:

      Lo, J. C.; Yabe, Y.; Baran, P. S. A practical and catalytic reductive olefin coupling J. Am. Chem. Soc. 2014, 136, 1304
    45. 45
      Barker, T. J.; Boger, D. L. Fe(III)/NaBH4-mediated free radical hydrofluorination of unactivated alkenes J. Am. Chem. Soc. 2012, 134, 13588 13591
    46. 46
      Boger, D. L.; Brotherton, C. E. Total synthesis of azafluoranthene alkaloids: rufescine and imelutine J. Org. Chem. 1984, 49, 4050 4055
    47. 47
      Duflos, A.; Kruczynski, A.; Baret, J.-M. Novel aspects of natural and modified Vinca alkaloids Curr. Med. Chem., Anti-Cancer Agents 2002, 2, 55 75
    48. 48
      Campbell, E. L.; Skepper, C. K.; Sankar, K.; Duncan, K. K.; Boger, D. L. Transannular Diels–Alder/1,3-dipolar cycloaddition cascade of 1,3,4-oxadiazoles: total synthesis of a unique set of vinblastine analogues Org. Lett. 2013, 15, 5306 5309
    49. 49
      Roepke, J.; Salim, V.; Wu, M.; Thamm, A. M. K.; Murata, J.; Ploss, K.; Boland, W.; De Luca, V. Vinca drug components accumulate exclusively in leaf exudates of Madagascar periwinkle Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 15287 15292
    50. 50
      Once in a while you receive a valued gift if you ask the right question at the right time. Personal communication: Otis, Hutchinson, KS (1971) .

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

You’ve supercharged your research process with ACS and Mendeley!

STEP 1:
Click to create an ACS ID

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

MENDELEY PAIRING EXPIRED
Your Mendeley pairing has expired. Please reconnect